The use of high-dose isomazid in intermittent regime TB treatment--some preliminary findings.
Ramasamy
R
R
Reginald
A
A
Ganesan
E
E
D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000009:adverse effects; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage* / Q000009:adverse effects; D010865:Pilot Projects; D017211:Treatment Failure; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology
D000995:Antitubercular Agents; D007538:Isoniazid